65 related articles for article (PubMed ID: 7580837)
1. Which nutrient supplements for optimal HIV-1 production by cultured human lymphocytes?
Landureau JC; Achour A; Fouchard M; M'Bika JP; Mazière JC; Zagury D
Cell Mol Biol (Noisy-le-grand); 1995 May; 41(3):423-30. PubMed ID: 7580837
[TBL] [Abstract][Full Text] [Related]
2. The influence of cell culture and storage conditions on HIV-1 infectivity and fusogenic activity.
Ongrádi J; Ceccherini-Nelli L; Szilágyi JF; Specter S; Pistello M; Laird HM; Bendinelli M
Acta Microbiol Hung; 1992; 39(3-4):207-21. PubMed ID: 1285337
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of HIV-1 replication by cyclopentenone prostaglandins in acutely infected human cells. Evidence for a transcriptional block.
Rozera C; Carattoli A; De Marco A; Amici C; Giorgi C; Santoro MG
J Clin Invest; 1996 Apr; 97(8):1795-803. PubMed ID: 8621762
[TBL] [Abstract][Full Text] [Related]
4. Role of potassium in human immunodeficiency virus production and cytopathic effects.
Choi B; Gatti PJ; Haislip AM; Fermin CD; Garry RF
Virology; 1998 Aug; 247(2):189-99. PubMed ID: 9705912
[TBL] [Abstract][Full Text] [Related]
5. Production of human immunodeficiency virus by chronically infected cells grown in protein-free medium.
Pintér C; Siccardi AG; Clivio A
Cell Biol Int; 1995 Jun; 19(6):507-15. PubMed ID: 7640665
[TBL] [Abstract][Full Text] [Related]
6. Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme.
Back NK; Nijhuis M; Keulen W; Boucher CA; Oude Essink BO; van Kuilenburg AB; van Gennip AH; Berkhout B
EMBO J; 1996 Aug; 15(15):4040-9. PubMed ID: 8670908
[TBL] [Abstract][Full Text] [Related]
7. Reverse transcriptase (RT)-independent as well as RT-dependent HIV-1 replication exists in syncytia following cell fusion.
Takami Y; Ito M; Baba M; Ikuta K; Tanabe F; Shigeta S
Fukushima J Med Sci; 1999 Jun; 45(1):13-24. PubMed ID: 10748552
[TBL] [Abstract][Full Text] [Related]
8. Effect of alpha-1 antitrypsin Portland variant (alpha 1-PDX) on HIV-1 replication.
Bahbouhi B; Bendjennat M; Guétard D; Seidah NG; Bahraoui E
Biochem J; 2000 Nov; 352 Pt 1(Pt 1):91-8. PubMed ID: 11062061
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human immunodeficiency virus type 1 replication by siRNA targeted to the highly conserved primer binding site.
Han W; Wind-Rotolo M; Kirkman RL; Morrow CD
Virology; 2004 Dec; 330(1):221-32. PubMed ID: 15527848
[TBL] [Abstract][Full Text] [Related]
10. Gradual shutdown of virus production resulting in latency is the norm during the chronic phase of human immunodeficiency virus replication and differential rates and mechanisms of shutdown are determined by viral sequences.
Li XD; Moore B; Cloyd MW
Virology; 1996 Nov; 225(1):196-212. PubMed ID: 8918547
[TBL] [Abstract][Full Text] [Related]
11. Preliminary in vitro growth cycle and transmission studies of HIV-1 in an autologous primary cell assay of blood-derived macrophages and peripheral blood mononuclear cells.
Tsai WP; Conley SR; Kung HF; Garrity RR; Nara PL
Virology; 1996 Dec; 226(2):205-16. PubMed ID: 8955040
[TBL] [Abstract][Full Text] [Related]
12. Suitability of MDCK cells grown in a serum-free medium for influenza virus production.
Kessler N; Thomas-Roche G; Gérentes L; Aymard M
Dev Biol Stand; 1999; 98():13-21; discussion 73-4. PubMed ID: 10494956
[TBL] [Abstract][Full Text] [Related]
13. Diminished efficiency of HIV-1 reverse transcriptase containing the K65R and M184V drug resistance mutations.
Frankel FA; Invernizzi CF; Oliveira M; Wainberg MA
AIDS; 2007 Mar; 21(6):665-75. PubMed ID: 17413687
[TBL] [Abstract][Full Text] [Related]
14. Autographa californica nucleopolyhedrovirus infection results in Sf9 cell cycle arrest at G2/M phase.
Braunagel SC; Parr R; Belyavskyi M; Summers MD
Virology; 1998 Apr; 244(1):195-211. PubMed ID: 9581791
[TBL] [Abstract][Full Text] [Related]
15. Altered replication of human immunodeficiency virus type 1 (HIV-1) in T cell lines retrovirally transduced to express Herpesvirus saimiri proteins StpC and/or Tip.
Henderson EE; Tsygankov AY; Merlo JJ; Romano G; Guan M
Virology; 1999 Nov; 264(1):125-33. PubMed ID: 10544137
[TBL] [Abstract][Full Text] [Related]
16. Purine ribonucleotide content in infected HIV-RT+ and HIV-RT- lymphoblastoid cell lines.
Carlucci F; Tabucchi A; Rosi F; Pagani R; Leoncini R; Pizzichini M; Marinello E
Biomed Pharmacother; 1996; 50(3-4):158-62. PubMed ID: 8881373
[TBL] [Abstract][Full Text] [Related]
17. Transformed lepidopteran cells expressing a protein of the silkmoth fat body display enhanced susceptibility to baculovirus infection and produce high titers of budded virus in serum-free media.
Iatrou K; Swevers L
J Biotechnol; 2005 Nov; 120(3):237-50. PubMed ID: 16233927
[TBL] [Abstract][Full Text] [Related]
18. Defined protein-free NS0 myeloma cell cultures: stimulation of proliferation by conditioned medium factors.
Spens E; Häggström L
Biotechnol Prog; 2005; 21(1):87-95. PubMed ID: 15903244
[TBL] [Abstract][Full Text] [Related]
19. Lovastatin inhibits HIV-1 expression in H9 human T lymphocytes cultured in cholesterol-poor medium.
Mazière JC; Landureau JC; Giral P; Auclair M; Fall L; Lachgar A; Achour A; Zagury D
Biomed Pharmacother; 1994; 48(2):63-7. PubMed ID: 7522603
[TBL] [Abstract][Full Text] [Related]
20. Amplification of human immuno-deficiency virus production from a virus-producing cell line in culture at high cell density.
Ikuta K; Imai H; Ueda S; Suehiro S; Yamamoto N; Kato S
Jpn J Cancer Res; 1987 Jul; 78(7):643-7. PubMed ID: 3114193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
